The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute (TMHRI) was formed in 2004 to rapidly and efficiently translate discoveries made in the laboratory and the clinic into new diagnostics, therapies, and treatments. Important advances in biomedical sciences and healthcare are made by collaborative, interdisciplinary teams of individuals with diverse scientific backgrounds and training. TMHRI was created to provide the infrastructure and support for these endeavors, and to house the technology and resources needed to make innovative breakthroughs in important areas of human disease.
The Office of Technology Transfer supports the TMHRI mission of conducting groundbreaking translational and clinical research to provide the best possible patient care by developing improved research tools, methods and devices to further advance research as well as promoting the commercialization of new drugs, diagnostics and treatments into the community.
Innovations (22):
- Network-based Signatures for Drug Repositioning (13 MAR 12)
- Quantitative Measurement of DNA Damage Using a Modified TUNEL Assay (16 JAN 12)
- Direct and Quantitative Measurement of Cell Death with Blunt-ended and Overhanging DNA Probes (16 JAN 12)
- Hydroxyapatite (HA) targeting peptide (16 JAN 12)
- Targeted Carbon Nanovectors for Treatment of Brain Cancer (16 JAN 12)
- Novel Mitochondrial Targeted Glioblastoma Drugs (16 JAN 12)
- Articulating Tissue Clamp (16 SEP 11)
- Highly Efficient 3-D Ellipsoidal Helix Antenna for Medical Implant Applications (05 AUG 11)
- Highly Potent Fluorescent Multivalent Integrin Antagonists for Targeted Therapy and Imaging (30 JUN 11)
- Quantitative Fluorescence Standards (30 JUN 11)
Find more innovations
